Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$27,179,640
+$1,237,036 QoQ
Shares Held
75,057
+1.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#317
of 3,140 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SUMMITRY LLC holds $46,849,010 across 11 Drug Manufacturers - General names. AMGN ranks #1 (58.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
75,057 | $27,179,640 | |
| 2 | JNJ |
Johnson & Johnson
|
51,089 | $12,975,073 | |
| 3 | LLY |
ELI LILLY & Co
|
1,711 | $2,052,224 | |
| 4 | ABBV |
AbbVie Inc.
|
4,563 | $1,148,233 | |
| 5 | BIIB |
Biogen Inc.
|
4,137 | $893,840 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,279 | $806,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,531 | $491,556 | |
| 8 | NVS |
Novartis AG
|
2,464 | $386,158 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,179,640 | 75,057 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $25,942,604 | 73,732 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $284,105 | 868 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $210,803 | 747 | Shares | Sole | 2025-11-07 | |
| 2021-03-31 | $263,738 | 1,060 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $243,715 | 1,060 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $269,409 | 1,060 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $200,481 | 850 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||